MedTrace Logo

Prognosis of Failure Treatment of Amebic Liver Abscess

NCT00641992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2008-03-24

No results posted yet for this study

Summary

Amebic liver abscess is the most frequent extra-intestinal form of the amoebiasis; actually the factors for predicting failure in the medical treatment are not clear. We conducted trial for determining the clinical value of paraclinical factor in this issue.

Conditions

  • Amebic Liver Abscess

Sponsors & Collaborators

  • Universidad Nacional Autonoma de Mexico

    collaborator OTHER

  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

    collaborator OTHER

  • Hospital Central "Dr. Ignacio Morones Prieto"

    collaborator OTHER

  • Universidad Autonoma de San Luis Potosí

    lead OTHER

Principal Investigators

  • Martín Sánchez-Aguilar 1, MSc · 1. Department of Experimental Surgery, Faculty of Medicine, Universidad Autónoma de San Luis Potosí

  • Onofre Morán-Mendoza, PhD · Department of Clinical Epidemiology, Faculty of Medicine, Universidad Autónoma de San Luis Potosí

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-05-31
Primary Completion
2000-04-30
Completion
2000-04-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00641992 on ClinicalTrials.gov